Home
>
National Drug Code (NDC)
>
Bupropion Hydrochloride
Bupropion Hydrochloride - 67767-135-60 - (Bupropion Hydrochloride)
Drug Information of Bupropion Hydrochloride
| Product NDC: | 67767-135 |
| Proprietary Name: | Bupropion Hydrochloride |
| Non Proprietary Name: | Bupropion Hydrochloride |
| Active Ingredient(s): | 200 mg/1 & nbsp; Bupropion Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Bupropion Hydrochloride
| Product NDC: | 67767-135 |
| Labeler Name: | Actavis South Atlantic LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077455 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100719 |
Package Information of Bupropion Hydrochloride
| Package NDC: | 67767-135-60 |
| Package Description: | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (67767-135-60) |
NDC Information of Bupropion Hydrochloride
| NDC Code | 67767-135-60 |
| Proprietary Name | Bupropion Hydrochloride |
| Package Description | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (67767-135-60) |
| Product NDC | 67767-135 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Bupropion Hydrochloride |
| Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20100719 |
| Marketing Category Name | ANDA |
| Labeler Name | Actavis South Atlantic LLC |
| Substance Name | BUPROPION HYDROCHLORIDE |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA] |
